Medtronic amends credit facility extending maturity to Dec 2026 and reducing borrowing costs

Medtronic plc

Extended credit facility maturity from Dec 12, 2025 to Dec 12, 2026; removed cap on future extensions.
Reduced interest rate margins to 0.50%-1.00% over LIBOR and commitment fee to 0.045%-0.090% per annum.
Replaced LIBOR benchmarks for GBP, JPY, and EUR with successor rates due to LIBOR cessation.
Shareholders approved 2021 Long Term Incentive Plan and authorized overseas share repurchases.
All 10 directors re-elected; say-on-pay passed with 90.3% support; auditor ratified.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.